Table 3.
Population results of the responders for the double-dose experiments
| Group | Responders/total | % responders |
| Wild type, IL-1β 1st dose → IL-1β 2nd dose | 5/7 | 71.4 |
| Wild type, TNF 1st dose → TNF 2nd dose | 4/6 | 66.7 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.